BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33821218)

  • 1. Integrative bioinformatics analysis of KPNA2 in six major human cancers.
    Xu C; Liu M
    Open Med (Wars); 2021; 16(1):498-511. PubMed ID: 33821218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyses of DNA Methylation Involved in the Activation of Nuclear Karyopherin Alpha 2 Leading to Identify the Progression and Prognostic Significance Across Human Breast Cancer.
    Cui X; Jing X; Wu X; Xu J; Liu Z; Huo K; Wang H
    Cancer Manag Res; 2020; 12():6665-6677. PubMed ID: 32801900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic role of karyopherin α2 (KPNA2) in human tumors: A pan-cancer analysis.
    Sun Y; Li W; Li X; Zheng H; Qiu Y; Yang H
    Comput Biol Med; 2021 Dec; 139():104955. PubMed ID: 34735944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of KPNA2 predicts unfavorable prognosis in ovarian cancer patients, possibly by targeting KIF4A signaling.
    Cui X; Wang H; Wu X; Huo K; Jing X
    J Ovarian Res; 2021 May; 14(1):71. PubMed ID: 34034774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
    Li Z; Lin Y; Cheng B; Zhang Q; Cai Y
    Front Genet; 2021; 12():571231. PubMed ID: 33767726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eleven genes associated with progression and prognosis of endometrial cancer (EC) identified by comprehensive bioinformatics analysis.
    Liu J; Zhou S; Li S; Jiang Y; Wan Y; Ma X; Cheng W
    Cancer Cell Int; 2019; 19():136. PubMed ID: 31139013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hub genes and biological pathways in hepatocellular carcinoma by integrated bioinformatics analysis.
    Zhao Q; Zhang Y; Shao S; Sun Y; Lin Z
    PeerJ; 2021; 9():e10594. PubMed ID: 33552715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Karyopherin subunit-α 2 expression accelerates cell cycle progression by upregulating CCNB2 and CDK1 in hepatocellular carcinoma.
    Gao CL; Wang GW; Yang GQ; Yang H; Zhuang L
    Oncol Lett; 2018 Mar; 15(3):2815-2820. PubMed ID: 29435009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRF1 Negatively Regulates Oncogenic KPNA2 Expression Under Growth Stimulation and Hypoxia in Lung Cancer Cells.
    Huang JX; Wu YC; Cheng YY; Wang CL; Yu CJ
    Onco Targets Ther; 2019; 12():11475-11486. PubMed ID: 31920336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyzing the prognostic value of DKK1 expression in human cancers based on bioinformatics.
    Wei R; Rodrìguez RA; Mullor MDMR; Tan Z; Gui Y; Hu J; Zhu T; Huang X; Zhu Y; Xu J
    Ann Transl Med; 2020 Apr; 8(8):552. PubMed ID: 32411775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated KPNA2 promotes hepatocellular carcinoma progression and indicates prognostic significance across human cancer types.
    Guo X; Wang Z; Zhang J; Xu Q; Hou G; Yang Y; Dong C; Liu G; Liang C; Liu L; Zhou W; Liu H
    Acta Biochim Biophys Sin (Shanghai); 2019 Mar; 51(3):285-292. PubMed ID: 30883648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
    Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation Between High Expression of FOXA2 and Improved Overall Survival in Ovarian Cancer Patients.
    Shang H; Shi L; Jiang X; Zhou P; Wei Y
    Med Sci Monit; 2021 Jan; 27():e928763. PubMed ID: 33483461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma.
    Guan R; Hong W; Huang J; Peng T; Zhao Z; Lin Y; Yu M; Jian Z
    J Gastrointest Oncol; 2020 Dec; 11(6):1305-1321. PubMed ID: 33457003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying
    Ding J; Liu Y; Lai Y
    PeerJ; 2020; 8():e10419. PubMed ID: 33282565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative Bioinformatics approaches to therapeutic gene target selection in various cancers for Nitroglycerin.
    Chinnappan J; Ramu A; V VR; S AK
    Sci Rep; 2021 Nov; 11(1):22036. PubMed ID: 34764329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KPNA2-Associated Immune Analyses Highlight the Dysregulation and Prognostic Effects of GRB2, NRAS, and Their RNA-Binding Proteins in Hepatocellular Carcinoma.
    Zhang X; Zhang J; Gao F; Fan S; Dai L; Zhang J
    Front Genet; 2020; 11():593273. PubMed ID: 33193737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.